Retatrutide 40mg

Retatrutide is a peptide-based medication that acts as a triple hormone receptor agonist. It simultaneously activates three key metabolic receptors:

• GLP-1 (glucagon-like peptide-1) receptor
• GIP (glucose-dependent insulinotropic polypeptide) receptor
• Glucagon receptor

This triple mechanism is designed to influence appetite, how the body uses energy, and glucose regulation more powerfully than current single or dual-agonist drugs.

How It Works

Retatrutide combines three hormonal effects in one molecule:

1. Appetite Suppression & Satiety
   • Activates GLP-1 pathways — reduces hunger signals and slows gastric emptying so people feel full sooner and eat less.
2. Improved Metabolic Control
   • Through GIP activation, it enhances insulin release after food intake and helps regulate blood sugar.
3. Increased Energy Use & Fat Breakdown
   • Glucagon activation helps increase energy expenditure and fat oxidation (burning fat for energy).

The combination results in strong appetite control, improved glucose handling, and greater metabolic effects than medications that act on only one or two of these pathways.

Retatrutide Uses

Current Uses Include:

• Treatment of obesity and overweight – showing significant weight loss in trials.
• Type 2 diabetes – potential to improve blood sugar and insulin responses.
• Metabolic dysfunction-associated steatotic liver disease (MASH) and cardiovascular risk markers – under investigation.
• Knee osteoarthritis, sleep apnea, and other related conditions are being explored